Cargando…

Stress-activated kinases as therapeutic targets in pancreatic cancer

Pancreatic cancer is a dismal disease with high incidence and poor survival rates. With the aim to improve overall survival of pancreatic cancer patients, new therapeutic approaches are urgently needed. Protein kinases are key regulatory players in basically all stages of development, maintaining ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traub, Benno, Roth, Aileen, Kornmann, Marko, Knippschild, Uwe, Bischof, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384741/ https://www.ncbi.nlm.nih.gov/pubmed/34497429 http://dx.doi.org/10.3748/wjg.v27.i30.4963

Ejemplares similares

c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1
por: Tian, Xiaodong, et al.
Publicado: (2021)

Endogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo
por: Traub, Benno, et al.
Publicado: (2017)

Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
por: Shi, Jingwei, et al.
Publicado: (2021)

Assessing the Inhibitory Potential of Kinase Inhibitors In Vitro: Major Pitfalls and Suggestions for Improving Comparability of Data Using CK1 Inhibitors as an Example
por: Roth, Aileen, et al.
Publicado: (2021)

Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
por: Lu, Jian, et al.
Publicado: (2023)

CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes
por: Roth, Aileen, et al.
Publicado: (2022)

Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
por: Shen, Xiao, et al.
Publicado: (2023)

Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer
por: Song, Xujun, et al.
Publicado: (2021)

Influence of bariatric surgery on the peripheral blood immune system of female patients with morbid obesity revealed by high-dimensional mass cytometry
por: Gihring, Adrian, et al.
Publicado: (2023)

Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer’s Disease
por: Roth, Aileen, et al.
Publicado: (2022)

JNK inhibitor IX restrains pancreatic cancer through p53 and p21
por: Shi, Jingwei, et al.
Publicado: (2022)

Loss of Interleukin-13-Receptor-Alpha-1 Induces Apoptosis and Promotes EMT in Pancreatic Cancer
por: Shi, Jingwei, et al.
Publicado: (2022)

CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP
por: Roth, Aileen, et al.
Publicado: (2021)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

CK1δ Kinase Activity Is Modulated by Chk1-Mediated Phosphorylation
por: Bischof, Joachim, et al.
Publicado: (2013)

Obesity Prolongs the Inflammatory Response in Mice After Severe Trauma and Attenuates the Splenic Response to the Inflammatory Reflex
por: Gärtner, Fabian, et al.
Publicado: (2021)

Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines
por: Liu, Congxing, et al.
Publicado: (2019)

Neurite Outgrowth of Mature Retinal Ganglion Cells and PC12 Cells Requires Activity of CK1δ and CK1ε
por: Bischof, Joachim, et al.
Publicado: (2011)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
por: Creeden, Justin F., et al.
Publicado: (2020)

The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
por: García-Reyes, Balbina, et al.
Publicado: (2018)

Brain Metastasis in Pancreatic Cancer
por: Lemke, Johannes, et al.
Publicado: (2013)

Identification of the Host Substratome of Leishmania-Secreted Casein Kinase 1 Using a SILAC-Based Quantitative Mass Spectrometry Assay
por: Smirlis, Despina, et al.
Publicado: (2022)

Impact of perioperative steroid administration in patients undergoing elective liver resection: meta-analysis
por: Jötten, Laila, et al.
Publicado: (2022)

The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
por: Knippschild, Uwe, et al.
Publicado: (2014)

The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer
por: Friedman, Eileen
Publicado: (2010)

Robotic Liver Surgery for Alveolar Echinococcosis: A Single-Centre Experience
por: Steinkraus, Kira C., et al.
Publicado: (2022)

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells
por: Burster, Timo, et al.
Publicado: (2021)

Diagnostic, Structured Classification and Therapeutic Approach in Cystic Pancreatic Lesions: Systematic Findings with Regard to the European Guidelines
por: Kloth, Christopher, et al.
Publicado: (2023)

A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε
por: Dolde, Christine, et al.
Publicado: (2018)

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK
por: Halekotte, Jakob, et al.
Publicado: (2017)

The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review
por: Chen, Kai, et al.
Publicado: (2021)

Dangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion
por: Rachidi, Najma, et al.
Publicado: (2021)

Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
por: Kretz, Anna-Laura, et al.
Publicado: (2018)

The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
por: Kumar, Ashna A., et al.
Publicado: (2022)

Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers
por: Jeoung, Nam Ho
Publicado: (2015)

Editorial: Cell Death and Targeted Cancer Therapies
por: Bagci-Onder, Tugba, et al.
Publicado: (2022)

2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε
por: Bischof, Joachim, et al.
Publicado: (2012)

Autophagy as a therapeutic target in pancreatic cancer
por: Piffoux, Max, et al.
Publicado: (2020)

MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer
por: Li, Yiwei, et al.
Publicado: (2016)

Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
por: Smigiel, Jacob M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qel1bkmjhtqsb4edm9fedjmfl3